Effect of albendazole on recurrent and residual alveolar echinococcosis of the liver after surgery

Hepatology

Volumn 25, Issue 3, 1997, Pages 528-531

  Ishizu, Hiroyuki ^a   Uchino, Junichi ^a   Sato, Naoki ^a   Aoki, Shigeru ^a   Suzuki, Kiyoshige ^a   Kuribayashi, Hiroshi ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Municipal Nakashibetsu Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; LIVER HYDATID CYST; LIVER RESECTION; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENT DISEASE;

ADULT; AGED; ALBENDAZOLE; ANTHELMINTICS; COMBINED MODALITY THERAPY; ECHINOCOCCOSIS, HEPATIC; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031043704     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250305     Document Type: Article

References (19)

1. Uchino J, Sato N, Nakajima T, Matsushita M, Takahashi M, Une Y. Treatment. In: Uchino J, Sato N, eds. Hokkaido University Medical Library Series. Vol 30. Sapporo, Japan: Kokoku Printing, 1993:137-149.
2. Ammann RW, Ilitsch N, Marincek B, Freiburghaus AU, The Swiss Echinococcosis Study Group. Effect of chemotherapy on the larval mass and the long-term course of alveolar echinococcosis. HEPATOLOGY 1994;19:735-742.
3. Davis A, Pawlowski ZS, Dixon H. Multicentre clinical trials of benzimidazolecarbamates in human echinococcosis. Bull WHO 1986;64:383-388.
4. Brimblecombe RW. Eskazole (Albendazole) 400 mg Tablets-Part I: Expert Report on Clinical Document report by SmithKline Company March, 1989.
5. Wen H, Zou PF, Yang WG, Lu J, Wang YH, Zhang JH, New RRC, et al. Albendazole chemotherapy for human cystic and alveolar echinococcosis in north-western China. Trans R Soc Trop Med Hyg 1994;88:340-343.
6. Rausch RL, Wilson JF, McMahon BJ, O'Gorman MA. Consequences of continuous mebendazole therapy in alveolar hydatid disease: with a summary of a ten-year clinical trial. Ann Trop Med Parasitol 1986;80:403-419.
7. Sato N, Uchino J, Aoki S, Taguchi K, Nishikawa M, Baba E, Nakagawa T, et al. Efficacy of benzimidazole-type drugs on alveolar echinococcosis (AE). Jpn Soc Gastroenterol 1994;91:1197-1204.
8. Schantz PM, Van den Bosche H, Eckert J. Chemotherapy for larval echinococcosis in animals and humans: Report of a workshop. Z Parasitenkde 1982;67:5-26.
9. Wilson JF, Rausch RL, McMahon BJ, Schantz PM. Parasitocidal effect of chemotherapy in alveolar hydatid disease: review of experience with mebendazole and albendazole in Alaskan Eskimos. Clin Infect Dis 1992;15:234-249.
10. Nakajima Y, Sato N, Uchino J. Stage of the disease. In: Uchino J, Sato N, eds. Hokkaido University Medical Library Series. Vol 30. Sapporo, Japan: Kokoku Printing, 1993:115-119.
11. Morris DL, Dykes PW, Dickson B, Marriner SE, Bogan JA, Burrows FGO. Albendazole in hydatid disease. Br J Med 1983;286:103-104.
12. Morris DL, Skene-Smith H, Haynes A, Burrows FGO. Abdominal hydatid disease: complete tomographic and ultrasound changes during albendazole therapy. Clin Radiol 1984;35:297-300.
13. Didier D, Weiler S, Rohmer P, Lassegue A, Deschamps JP, Vuitton D, Miguet JP, et al. Hepatic alveolar echinococcosis: correlative US and CT study. Radiology 1987;154:179-186.
14. Liu YH, Wang XG, Chen YT, Yao YQ. Computer tomography of the liver in alveolar echinococcosis treated with albendazole. Trans R Soc Trop Med Hyg 1993;87:319-321.
15. Rausch RL, Wilson JF, Schantz PM, McMahon BJ. Spontaneous death of echinococcus multilocularis: cases diagnosed serologically (by Em2 ELISA) and clinical significance. Am J Trop Med Hyg 1987;36:576-585.
16. Uchino J, Sato N. Prognosis. In: Uchino J, Sato N, eds. Hokkaido University Medical Library Series. Vol 30. Sapporo, Japan: Kokoku Printing, 1993:177-179.
17. Mesarina B. Long-term course of alveolar echinococcosis in 70 patients treated by benzimidazole derivatives (1976-89) (Thesis). Zurich: University of Zurich, 1991:22.
18. Ammann R, Hirsbrunner R, Getting J, Steiger U, Jacquier P, Eckert J. Recurrence rate after discontinuation of long-term mebendazole. Am J Trop Med Hyg 1990;43:506-515.
19. Schantz PM, Wilson JF, Wahlquist SP, Boss LP, Rausch RL. Serological tests for diagnosis and post-treatment evaluation of patients with alveolar hydatid disease (Echinococcus multilocularis). Am J Trop Med Hyg 1983;32:1381-1386.